Status of Antibiotic Susceptibility of Polymyxin B And Colistin in the Treatment of Carbapenem Resistant Gram Negative Bacterial Infections: An Observational Study. [PDF]
JNMA J Nepal Med AssocBhattarai AK, Pokharel K, Shrestha MV.
europepmc +1 more source
Hyperforin potentiates polymyxin B against multidrug-resistant Gram-negative pathogens via membrane disruption, biofilm eradication, and oxidative stress. [PDF]
Antimicrob Agents ChemotherHussein M +9 more
europepmc +1 more source
Synergistic activity of rifampicin and polymyxin B against intracellular Gram-negative ESKAPE pathogens involves bacterial membrane alterations and enhanced oxidative damages. [PDF]
Antimicrob Agents ChemotherVarik V +6 more
europepmc +1 more source
Discovery of antimicrobial peptides targeting Acinetobacter baumannii via a pre-trained and fine-tuned few-shot learning-based pipeline. [PDF]
Nat CommunHuang J +9 more
europepmc +1 more source
Polymyxin resistance in Gram-negative bacteria: a comprehensive review with a focus on the role of 4-amino-4-doexy-L-arabinose. [PDF]
Mol Biol RepSasal WM, Gmiter D, Kaca W.
europepmc +1 more source
Introducing CLipPA lipid chemodiversity to enzymatically truncated polymyxin B: a soft drug strategy to combat Gram-negative pathogens. [PDF]
RSC Med ChemNa TU +17 more
europepmc +1 more source
Novel cationic peptide OB1111 is a dual anti-planktonic and anti-biofilm agent against P. aeruginosa strains PA14 and PAO1. [PDF]
BMC MicrobiolGrace A +6 more
europepmc +1 more source